Advertisement
Advertisement

IMDX

IMDX logo

Insight Molecular Diagnostics Inc. Common Stock

5.38
USD
Sponsored
+0.01
+0.19%
Jun 24, 15:59 UTC -4
Closed
exchange

After-Market

5.41

+0.03
+0.56%

IMDX Earnings Reports

Positive Surprise Ratio

IMDX beat 16 of 42 last estimates.

38%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$446.25K
/
-$0.25
Implied change from Q1 26 (Revenue/ EPS)
+1294.53%
/
+108.33%
Implied change from Q2 25 (Revenue/ EPS)
-13.85%
/
-16.67%

Insight Molecular Diagnostics Inc. Common Stock earnings per share and revenue

On May 13, 2026, IMDX reported earnings of -0.12 USD per share (EPS) for Q1 26, beating the estimate of -0.26 USD, resulting in a 55.01% surprise. Revenue reached 32.00 thousand, compared to an expected 306.00 thousand, with a -89.54% difference. The market reacted with a +25.88% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -0.25 USD, with revenue projected to reach 446.25 thousand USD, implying an increase of 108.33% EPS, and increase of 1294.53% in Revenue from the last quarter.
FAQ
For Q1 2026, Insight Molecular Diagnostics Inc. Common Stock reported EPS of -$0.12, beating estimates by 55.01%, and revenue of $32.00K, -89.54% below expectations.
The stock price moved up 25.88%, changed from $5.10 before the earnings release to $6.42 the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on 5 analysts, Insight Molecular Diagnostics Inc. Common Stock is expected to report EPS of -$0.25 and revenue of $446.25K for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement